The effect of phosphorylation on amphetamine-mediated outward transport

European Journal of Pharmacology

Volumn 479, Issue 1-3, 2003, Pages 83-91

  Gnegy, Margaret E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dopamine release; Dopamine transporter; Norepinephrine transporter; PC12 cell; Protein kinase C; Striatum

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CHELERYTHRINE; DIOCTANOIN; DOPAMINE TRANSPORTER; GLYCEROL 2 ACETATE 1 OLEATE; NEUROMODULIN; NORADRENALIN TRANSPORTER; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; SULPIRIDE;

CATECHOLAMINE RELEASE; CONCENTRATION RESPONSE; DOPAMINE RELEASE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; IC 50; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SYNAPSE;

EID: 0242660419     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.059     Document Type: Article

References (87)

1. Alexander K.A., Wakim B., Doyle G.S., Walsh K.A., Storm D.R. Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J. Biol. Chem. 263:1988;7544-7549.
2. Apparsundaram S., Galli A., DeFelice L.J., Hartzell H.C., Blakely R.D. Acute regulation of norepinephrine transport: I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287:1998;733-743.
3. Apparsundaram S., Schroeter S., Giovanetti E., Blakely R.D. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J. Pharmacol. Exp. Ther. 287:1998;744-751.
4. Bauman A.L., Apparsundaram S., Ramamoorthy S., Wadzinski B.E., Vaughan R.A., Blakely R.D. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20:2000;7571-7578.
5. Bonisch H. The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines. Naunyn-Schmied. Arch. Pharmacol. 332:1986;135-141.
6. Browman K.E., Kantor L., Richardson S., Badiani A., Robinson T.E., Gnegy M.E. Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res. 814:1998;112-119.
7. Bugnon O., Ofori S., Schorderet M. Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro. Naunyn-Schmied. Arch. Pharmacol. 351:1995;53-59.
8. Chang M.Y., Lee S.H., Kim J.H., Lee K.H., Kim Y.S., Son H., Lee Y.S. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. J. Neurochem. 77:2001;754-761.
9. Chen N., Justice J.B. Jr. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Brain Res. Mol. Br. Res. 75:2000;208-215.
10. Coggins P.J., Zwiers H. B-50 (GAP-43): biochemistry and functional neurochemistry of a neuron-specific phosphoprotein. J. Neurochem. 56:1991;1095-1106.
11. Cowell R.M., Kantor L., Hewlett G.H., Frey K.A., Gnegy M.E. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389:2000;59-65.
12. Davis M.E., Patrick R.L. Diacylglycerol-induced stimulation of neurotransmitter release from rat brain striatal synaptosomes. J. Neurochem. 54:1990;662-668.
13. Derbez A.E., Mody R.M., Werling L.L. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C. J. Pharmacol. Exp. Ther. 301:2002;306-314.
14. Doolen S., Zahniser N.R. Conventional protein kinase C isoforms regulate human dopamine transporter activity in Xenopus oocytes. FEBS Lett. 516:2002;187-190.
15. Drew A.E., Werling L.L. Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex. J. Neurochem. 77:2001;839-848.
16. Drew A.E., Derbez A.E., Werling L.L. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse. 38:2000;10-16.
17. Fleckenstein A.E., Wilkins D.G., Gibb J.W., Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5- hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 283:1997;281-285.
18. Floor E., Meng L. Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci. Lett. 215:1996;53-56.
19. Foster J.D., Pananusorn B., Vaughan R.A. Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277:2002;25178-25186.
20. Foster J.D., Pananusorn B., Cervinski M.A., Holden H.E., Vaughan R.A. Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Mol. Brain Res. 110:2003;100-108.
21. - in transport. Naunyn-Schmied. Arch. Pharmacol. 333:1986;246-252.
22. Giambalvo C.T. Protein kinase C and dopamine transport - 1. Effects of amphetamine in vivo. Neuropharmacol. 31:1992;1201-1210.
23. Giambalvo C.T. Protein kinase C and dopamine transport-2. Effects of amphetamine in vitro. Neuropharmacol. 31:1992;1211-1222.
24. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
25. Giros B., Wang Y.-M., Suter S., McLeskey S.B., Pifl C., Caron M.G. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269:1994;15985-15988.
26. Gluck M.R., Moy L.Y., Jayatilleke E., Hogan K.A., Manzino L., Sonsalla P.K. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J. Neurochem. 79:2001;152-160.
27. Gnegy M.E., Hong P., Ferrell S.T. Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res. Mol. Br. Res. 20:1993;289-298.
28. 2+ regulates amphetamine-mediated dopamine transporter currents and outward transport of dopamine in hDAT-HEK293 cells. Soc. Neurosci. Abs. 167.3:2003.
29. Granas C., Ferrer J., Loland C.J., Javitch J.A., Gether U. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278:2003;4990-5000.
30. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73:1976;2424-2428.
31. Gu H., Wall S.C., Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269:1994;7124-7130.
32. Gulley J.M., Doolen S., Zahniser N.R. Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J. Neurochem. 83:2002;400-411.
33. Hastrup H., Karlin A., Javitch J.A. Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10055-10060.
34. max. J. Neurochem. 68:1997;225-232.
35. Iwata S., Hewlett G.H., Ferrell S.T., Czernik A.J., Meiri K.F., Gnegy M.E. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp. Ther. 278:1996;1428-1434.
36. Iwata S., Hewlett G.H., Ferrell S.T., Kantor L., Gnegy M.E. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J. Pharmacol. Exp. Ther. 283:1997;1445-1452.
37. Iwata S., Hewlett G.H., Gnegy M.E. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse. 26:1997;281-291.
38. Izenwasser S., Thompson-Montgomery D., Deben S.E., Chowdhury I.N., Werling L.L. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists. Eur. J. Pharmacol. 346:1998;189-196.
39. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73:1999;2406-2414.
40. Kantor L., Gnegy M.E. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284:1998;594-598.
41. 2+ and protein kinases. Soc. Neurosci. Abs. 774.8:2001.
42. Kantor L., Hewlett G.H., Gnegy M.E. Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles. J. Neurosci. 19:1999;3801-3808.
43. Kantor L., Hewlett G.H., Park Y.H., Richardson-Burns S.M., Mellon M.J., Gnegy M.E. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J. Pharmacol. Exp. Ther. 297:2001;1016-1024.
44. Kantor L., Park Y.H., Wang K.K.W., Gnegy M.E. Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment. Eur. J. Pharmacol. 451:2002;27-35.
45. +-dependent mechanism. J. Biol. Chem. 278:2003;12070-12077.
46. Kittner B., Brautigam M., Herken H. PC12 cells: a model system for studying drug effects on dopamine synthesis and release. Arch. Int. Pharmacodyn. Ther. 286:1987;181-194.
47. Knapp L.T., Klann E. Potentiation of hippocampal synaptic transmission by superoxide requires the oxidative activation of protein kinase C. J. Neurosci. 22:2002;674-683.
48. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsych. Clin. Neurosci. 9:1997;482-497.
49. Kramer H.K., Poblete J.C., Azmitia E.C. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT). Neuropsychopharmacol. 19:1998;265-277.
50. Krivanek J. Protein kinase C in the parabrachial nucleus of rats during conditioned taste aversion induced by amphetamine. Neurosci. Lett. 236:1997;17-20.
51. Loder M.K., Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278:2003;22168-22174.
52. Lotharius J., O'Malley K.L. Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Ann. Neurol. 49:2001;79-89.
53. Mundorf M.L., Hochstetler S.E., Wightman R.M. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem. 73:1999;2397-2405.
54. Page G., Peeters M., Najimi M., Maloteaux J.M., Hermans E. Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J. Neurochem. 76:2001;1282-1290.
55. Park S.U., Ferrer J.V., Javitch J.A., Kuhn D.M. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22:2002;4399-4405.
56. Pierce R.C., Kalivas P.W. The enhanced releasability of nucleus accumbens shell dopamine in rats behaviorally sensitized to cocaine is calcium-dependent. Soc. Neurosci. Abs. 21:1995;714.
57. Pierce R.C., Quick E.A., Reeder D.C., Morgan Z.R., Kalivas P.W. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 286:1998;1171-1176.
58. Pifl C., Singer E.A. Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 56:1999;1047-1054.
59. Reith M.E., Xu C., Chen N.H. Pharmacology and regulation of the neuronal dopamine transporter. Eur. J. Pharmacol. 324:1997;1-10.
60. Robinson P.J. The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release. Mol. Neurobiol. 5:1991;87-130.
61. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
62. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:2001;32-41.
63. Rutledge C.O. Effect of metabolic inhibitors and ouabain on amphetamine- and potassium-induced release of biogenic amines from isolated brain tissue. Biochem. Pharmacol. 27:1978;511-516.
64. Sammet S., Graefe K.H. Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport. Naunyn-Schmied. Arch. Pharmacol. 309:1979;99-107.
65. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., Leeb-Lundberg L.M., Carvelli L., Javitch J.A., Galli A. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6850-6855.
66. Scholze P., Norregaard L., Singer E.A., Freissmuth M., Gether U., Sitte H.H. The role of zinc ions in reverse transport mediated by monoamine transporters. J. Biol. Chem. 277:2002;21505-21513.
67. Sitte H.H., Huck S., Reither H., Boehm S., Singer E.A., Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem. 71:1998;1289-1297.
68. Sitte H.H., Hiptmair B., Zwach J., Pifl C., Singer E.A., Scholze P. Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 59:2001;1129-1137.
69. Skene J.H. GAP-43 as a 'calmodulin sponge' and some implications for calcium signalling in axon terminals. Neurosci. Res. Suppl. 13:1990;S112-S125.
70. Stein W.D. Channels, Carriers and Pumps. An Introduction to Membrane Transport. 1990;Academic Pr. San Diego.
71. Sulzer D., Chen T.-K., Lau Y.Y., Kristensen H., Rayport S., Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15:1995;4102-4108.
72. Sung U., Apparsundaram S., Galli A., Kahlig K.M., Savchenko V., Schroeter S., Quick M.W., Blakely R.D. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J. Neurosci. 23:2003;1697-1709.
73. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., Staudinger J., Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 30:2001;121-134.
74. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D., Caron M.G. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J. Biol. Chem. 278:2003;2731-2739.
75. 3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases. Brain Res. 809:1998;155-164.
76. 3H]dopamine uptake in rat striatum: possible involvement of calmodulin-dependent kinases. J. Neurochem. 65:1995;2065-2071.
77. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272:1997;15541-15546.
78. Vaughan P.F., Walker J.H., Peers C. The regulation of neurotransmitter secretion by protein kinase C. Mol. Neurobiol. 18:1998;125-155.
79. Vislobokov A.I., Mantsev V.V., Kuzmin A.V. Cocaine, amphetamine and cathinone, but not nomifensine and pargyline increase calcium inward current in internally perfused neurons. Life Sci. 52:1993;PL261-PL265.
80. Wall S.C., Gu H., Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47:1995;544-550.
81. Wan F.J., Lin H.C., Lin Y.S., Tseng C.J. Intra-striatal infusion of D-amphetamine induces hydroxyl radical formation: inhibition by MK-801 pretreatment. Neuropharmacol. 39:2000;419-426.
82. Weatherspoon J.K., Werling L.L. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors. J. Pharmacol. Exp. Ther. 289:1999;278-284.
83. Wolf M.E., Xue C.J., Li Y., Wavak D. Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. J. Neurochem. 75:2000;1634-1644.
84. Yatin S.M., Miller G.M., Norton C., Madras B.K. Dopamine transporter-dependent induction of C-Fos in HEK cells. Synapse. 45:2002;52-65.
85. Zahniser N.R., Doolen S. Chronic and acute regulation of Na+/ Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92:2001;21-55.
86. Zhang L., Coffey L.L., Reith M.E.A. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53:1997;677-688.
87. Zhu J., Hexum T.D. Characterization of cocaine-sensitive dopamine uptake in PC12 cells. Neurochem. Int. 21:1992;521-526.